Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2004-2-9
pubmed:abstractText
A total of 76 patients discontinued treatment with didanosine plus hydroxyurea after 1 year of maintenance therapy. The greatest human immunodeficiency virus (HIV)-RNA rebounds were seen in 10 patients harboring an L74V mutation, and the presence of viruses with this mutation rapidly waned. In contrast, viral rebounds were significantly less pronounced (P < 0.01) in 12 subjects harboring thymidine-associated mutations; these mutations persisted in all instances. Thus, selection of an L74V mutation during didanosine therapy may compromise HIV replication in vivo.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/14766874-10482597, http://linkedlifedata.com/resource/pubmed/commentcorrection/14766874-10601505, http://linkedlifedata.com/resource/pubmed/commentcorrection/14766874-10634336, http://linkedlifedata.com/resource/pubmed/commentcorrection/14766874-10634339, http://linkedlifedata.com/resource/pubmed/commentcorrection/14766874-10708295, http://linkedlifedata.com/resource/pubmed/commentcorrection/14766874-10722492, http://linkedlifedata.com/resource/pubmed/commentcorrection/14766874-10877738, http://linkedlifedata.com/resource/pubmed/commentcorrection/14766874-11172188, http://linkedlifedata.com/resource/pubmed/commentcorrection/14766874-11416735, http://linkedlifedata.com/resource/pubmed/commentcorrection/14766874-11588505, http://linkedlifedata.com/resource/pubmed/commentcorrection/14766874-11919491, http://linkedlifedata.com/resource/pubmed/commentcorrection/14766874-12095387, http://linkedlifedata.com/resource/pubmed/commentcorrection/14766874-12210423, http://linkedlifedata.com/resource/pubmed/commentcorrection/14766874-12368352, http://linkedlifedata.com/resource/pubmed/commentcorrection/14766874-12370421, http://linkedlifedata.com/resource/pubmed/commentcorrection/14766874-12370434, http://linkedlifedata.com/resource/pubmed/commentcorrection/14766874-12441810, http://linkedlifedata.com/resource/pubmed/commentcorrection/14766874-12830416, http://linkedlifedata.com/resource/pubmed/commentcorrection/14766874-12837968, http://linkedlifedata.com/resource/pubmed/commentcorrection/14766874-7506280, http://linkedlifedata.com/resource/pubmed/commentcorrection/14766874-7969058, http://linkedlifedata.com/resource/pubmed/commentcorrection/14766874-8103317, http://linkedlifedata.com/resource/pubmed/commentcorrection/14766874-9343245, http://linkedlifedata.com/resource/pubmed/commentcorrection/14766874-9359660, http://linkedlifedata.com/resource/pubmed/commentcorrection/14766874-9683207
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0095-1137
pubmed:author
pubmed:issnType
Print
pubmed:volume
42
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
862-6
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Different viral rebound following discontinuation of antiretroviral therapy in cases of infection with viruses carrying L74V or thymidine-associated mutations.
pubmed:affiliation
Service of Infectious Diseases, Hospital Carlos III, Madrid, Spain.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't